Skin-whitening agent containing polyphenol compound
    1.
    发明申请
    Skin-whitening agent containing polyphenol compound 审中-公开
    含有多酚化合物的皮肤增白剂

    公开(公告)号:US20070189997A1

    公开(公告)日:2007-08-16

    申请号:US11708021

    申请日:2007-02-20

    IPC分类号: A61K8/31

    摘要: This invention relates to a method for inhibiting melanin formation in a subject comprising administering an effective amount of an acerola-derived polyphenol compound, an acerola polyphenol fraction, or the other polyphenol compound to a subject. This method comprises whitening the subject's skin by the inhibition of melanin formation. This method also comprises administering synergistically effective amounts of an acerola-derived polyphenol compound, an acerola polyphenol fraction, or the other polyphenol compound in combination with ascorbic acid or an ascorbic acid derivative to a subject.

    摘要翻译: 本发明涉及一种用于抑制受试者中黑色素形成的方法,包括向受试者施用有效量的来源于青蒿素的多酚化合物,痤疮多酚分子或其它多酚化合物。 该方法包括通过抑制黑色素形成来增白受试者的皮肤。 该方法还包括向受试者施用协同有效量的与来自抗坏血酸或抗坏血酸衍生物的协同有效量的源自多酚的多酚化合物,痤疮多酚部分或其它多酚化合物。

    SKIN-WHITENING AGENT CONTAINING POLYPHENOL COMPOUND
    2.
    发明申请
    SKIN-WHITENING AGENT CONTAINING POLYPHENOL COMPOUND 审中-公开
    含有聚苯醚化合物的皮肤白化剂

    公开(公告)号:US20090004311A1

    公开(公告)日:2009-01-01

    申请号:US12202721

    申请日:2008-09-02

    IPC分类号: A61K36/185 A23L1/302

    摘要: This invention relates to a method for inhibiting melanin formation in a subject comprising administering an effective amount of an acerola-derived polyphenol compound, an acerola polyphenol fraction, or the other polyphenol compound to a subject. This method comprises whitening the subject's skin by the inhibition of melanin formation. This method also comprises administering synergistically effective amounts of an acerola-derived polyphenol compound, an acerola polyphenol fraction, or the other polyphenol compound in combination with ascorbic acid or an ascorbic acid derivative to a subject.

    摘要翻译: 本发明涉及一种用于抑制受试者中黑色素形成的方法,包括向受试者施用有效量的来源于青蒿素的多酚化合物,痤疮多酚分子或其它多酚化合物。 该方法包括通过抑制黑色素形成来增白受试者的皮肤。 该方法还包括向受试者施用协同有效量的与来自抗坏血酸或抗坏血酸衍生物的协同有效量的源自多酚的多酚化合物,痤疮多酚部分或其它多酚化合物。